These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 6536604

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tatematsu M, Lurie AG, Rippey RM, Conran PB, Arai M, Fukushima S, Ito N.
    Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
    [Abstract] [Full Text] [Related]

  • 44. Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters.
    Fukushima S, Hirose M, Okuda M, Nakanowatari J, Hatano A, Ito N.
    Urol Res; 1982 Jan; 10(3):115-8. PubMed ID: 7135697
    [Abstract] [Full Text] [Related]

  • 45. Promotion by L-ascorbic acid of urinary bladder carcinogenesis in rats under conditions of increased urinary K ion concentration and pH.
    Fukushima S, Shibata M, Shirai T, Kurata Y, Tamano S, Imaida K.
    Cancer Res; 1987 Sep 15; 47(18):4821-4. PubMed ID: 3621178
    [Abstract] [Full Text] [Related]

  • 46. [Effect of intrabladder instillation of various anticancer agents on carcinogenesis in rat bladder].
    Okamura T.
    Hinyokika Kiyo; 1988 Nov 15; 34(11):1895-902. PubMed ID: 3149447
    [Abstract] [Full Text] [Related]

  • 47. Lack of a modifying effect by the diuretic drug furosemide on the development of neoplastic lesions in rat two-stage urinary bladder carcinogenesis.
    Shibata MA, Hagiwara A, Tamano S, Ono S, Fukushima S.
    J Toxicol Environ Health; 1989 Nov 15; 26(3):255-65. PubMed ID: 2926828
    [Abstract] [Full Text] [Related]

  • 48. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.
    Cancer Res; 1998 Sep 01; 58(17):3806-11. PubMed ID: 9731488
    [Abstract] [Full Text] [Related]

  • 49. Changes in urine composition, bladder epithelial morphology, and DNA synthesis in male F344 rats in response to ingestion of bladder tumor promoters.
    Shibata MA, Yamada M, Tanaka H, Kagawa M, Fukushima S.
    Toxicol Appl Pharmacol; 1989 Jun 01; 99(1):37-49. PubMed ID: 2727999
    [Abstract] [Full Text] [Related]

  • 50. Responses of rat urine and urothelium to bladder tumor promoters: possible roles of prostaglandin E2 and ascorbic acid synthesis in bladder carcinogenesis.
    Shibata MA, Yamada M, Asakawa E, Hagiwara A, Fukushima S.
    Carcinogenesis; 1989 Sep 01; 10(9):1651-6. PubMed ID: 2766457
    [Abstract] [Full Text] [Related]

  • 51. Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants.
    Ito N, Fukushima S, Tsuda H.
    Crit Rev Toxicol; 1985 Sep 01; 15(2):109-50. PubMed ID: 3899519
    [Abstract] [Full Text] [Related]

  • 52. F344/Shi rats bearing type b catalase-1 locus are sensitive to sodium L-ascorbate promotion of two-stage urinary bladder carcinogenesis.
    Mori S, Murai T, Hosono M, Yamashita H, Oohara T, Makino S, Doteuchi M, Fukushima S.
    Teratog Carcinog Mutagen; 1998 Sep 01; 18(1):27-33. PubMed ID: 9586768
    [Abstract] [Full Text] [Related]

  • 53. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Fukushima S, Kurata Y, Shibata M, Ikawa E, Ito N.
    Cancer Lett; 1984 May 01; 23(1):29-37. PubMed ID: 6744233
    [Abstract] [Full Text] [Related]

  • 54. Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
    Murai T, Mori S, Hosono M, Takashima A, Machino S, Oohara T, Yamashita H, Makino S, Matsuda T, Wanibuchi H, Fukushima S.
    Jpn J Cancer Res; 1997 Mar 01; 88(3):245-53. PubMed ID: 9140108
    [Abstract] [Full Text] [Related]

  • 55. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
    Okajima E, Hiramatsu T, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Tanaka M, Maruyama Y.
    Gan To Kagaku Ryoho; 1982 Mar 01; 9(3):473-9. PubMed ID: 6820898
    [Abstract] [Full Text] [Related]

  • 56. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, Kitayama W, Wakabayashi K, Konishi Y.
    Cancer Res; 1998 Jul 15; 58(14):3028-31. PubMed ID: 9679967
    [Abstract] [Full Text] [Related]

  • 57. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Shirai T, Takahashi S, Mutai M, Fukushima S.
    Carcinogenesis; 1988 Nov 15; 9(11):1981-5. PubMed ID: 3180336
    [Abstract] [Full Text] [Related]

  • 58. L-ascorbic acid amplification of second-stage bladder carcinogenesis promotion by NaHCO3.
    Fukushima S, Imaida K, Shibata MA, Tamano S, Kurata Y, Shirai T.
    Cancer Res; 1988 Nov 15; 48(22):6317-20. PubMed ID: 3180049
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine].
    Frolov AG, Pliss GB.
    Vopr Onkol; 1992 Nov 15; 38(11):1309-13. PubMed ID: 1343160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.